OncoMed Pharmaceuticals is discovering and developing novel therapeutics targeting cancer stem cells, the cells believed to be capable of driving tumor growth, recurrence and metastases. The company has established a library of antibodies to cancer stem cell proteins for the treatment of solid tumors such as breast, colon, prostate, and lung cancers. OncoMed is a leader in cancer stem cell research and the identification of novel cancer stem cell targets. Privately-held, the company’s investors include US Venture Partners, Latterell Venture Partners, Morgenthaler Ventures, The Vertical Group, Adams Street Partners, De Novo Ventures and Bay Partners.
(Source:OncoMed.com)
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 03/31/08 | Series A | 17.5M | HBM Bioventure, Wellcome Trust Limited, Tallwood L.P., Lotus BioScience Investment Holding, Alexandria Equities, Private | Unknown |
| 11/01/08 | Series B | 154M | Unknown |
People
Paul Hastings (President/CEO)
Lawrence Lasky (Board Member)
Jim Broderick (Board Member)
Michael Clarke (Founder, CEO, CTO)
Steven Benner (Chief Medical Officer)
View more details about all 24 people at OncoMed Pharmaceuticals
Competitors
Stemline Therapeutics:
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company and a leading developer of novel oncology… See Company Profile »
News
Morgenthaler Ventures closes $400M ninth fund
November 13, 2008 4:04 pm
updated Morgenthaler Ventures, a Menlo Park, Calif. venture firm focused on early-stage investments in information technology and life sciences, has… Continue reading ⟩
OncoMed nabs $93M for stem cell programs
November 5, 2008 3:00 am
OncoMed Pharmaceuticals, a company working to fight cancer using stem cells, added a $93 million tranche to a second round… Continue reading ⟩
Life-science briefing: Wednesday, April 9, 2008
April 9, 2008 8:31 pm
TODAY’S HEADLINES: Stemline Therapeutics, cancer stem-cell startup, gets $13M (release) Eye-disease biotech Potentia Pharma raises $12M (release) Sample-prep toolmaker Arcxis… Continue reading ⟩